Literature DB >> 22801938

Predictor of de novo stress urinary incontinence following TVM procedure: a further analysis of preoperative voiding function.

Masato Kuribayashi1, Yasuhide Kitagawa, Kazutaka Narimoto, Satoko Urata, Shohei Kawaguchi, Mikio Namiki.   

Abstract

INTRODUCTION AND HYPOTHESIS: The purpose of this study was to evaluate the predictors of de novo stress urinary incontinence (SUI) in patients undergoing a tension-free vaginal mesh procedure (TVM) for pelvic organ prolapse (POP).
METHODS: Sixty-five patients without SUI were assessed with regard to voiding function by a pressure flow study and clinical characteristics.
RESULTS: The mean age of the patients was 67 ± 8.3. Of the 65 patients, 41 (63 %) maintained urinary continence postoperatively and 24 (37 %) showed de novo SUI. In univariate analysis, the de novo SUI group included a significantly higher proportion of patients with preoperative obstruction, defined as moderate or greater obstruction according to the Blaivas nomogram (29 vs 7 %, P = 0.035). In multivariate analysis, urethral obstruction was an independent predictor of de novo SUI with an odds ratio of 12.616 (95 % confidence interval 1.580-268.731).
CONCLUSIONS: Preoperative evaluation of urethral obstruction will contribute to prediction of de novo SUI combined with a conventional diagnosis of occult SUI.

Entities:  

Mesh:

Year:  2012        PMID: 22801938     DOI: 10.1007/s00192-012-1882-0

Source DB:  PubMed          Journal:  Int Urogynecol J        ISSN: 0937-3462            Impact factor:   2.894


  25 in total

1.  Incidence of stress urinary incontinence following vaginal repair of pelvic organ prolapse in objectively continent women.

Authors:  Hazem Al-Mandeel; Sue Ross; Magali Robert; Jill Milne
Journal:  Neurourol Urodyn       Date:  2011-01-31       Impact factor: 2.696

2.  Stress Urinary Incontinence.

Authors:  E J McGuire; B Lytton; V Pepe; E I Kohorn
Journal:  Obstet Gynecol       Date:  1976-03       Impact factor: 7.661

3.  Clinical and urodynamic effects of anterior colporrhaphy and vaginal hysterectomy for prolapse with and without incontinence.

Authors:  S L Stanton; P Hilton; C Norton; L Cardozo
Journal:  Br J Obstet Gynaecol       Date:  1982-06

Review 4.  [Changing attitudes on the surgical treatment of urogenital prolapse: birth of the tension-free vaginal mesh].

Authors:  P Debodinance; J Berrocal; H Clavé; M Cosson; O Garbin; B Jacquetin; C Rosenthal; D Salet-Lizée; R Villet
Journal:  J Gynecol Obstet Biol Reprod (Paris)       Date:  2004-11

5.  Use of the Gynecare Prolift system in surgery for pelvic organ prolapse: 1-year outcome.

Authors:  Ganesh Raj Vaiyapuri; How Chuan Han; Lih Charn Lee; Leng Aun Arthur Tseng; Heng Fok Wong
Journal:  Int Urogynecol J       Date:  2011-04-09       Impact factor: 2.894

Review 6.  An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction.

Authors:  Bernard T Haylen; Dirk de Ridder; Robert M Freeman; Steven E Swift; Bary Berghmans; Joseph Lee; Ash Monga; Eckhard Petri; Diaa E Rizk; Peter K Sand; Gabriel N Schaer
Journal:  Int Urogynecol J       Date:  2009-11-25       Impact factor: 2.894

7.  Prevention of postoperative urinary stress incontinence after surgery for genitourinary prolapse.

Authors:  M Colombo; A Maggioni; G Zanetta; M Vignali; R Milani
Journal:  Obstet Gynecol       Date:  1996-02       Impact factor: 7.661

8.  Safety of Trans Vaginal Mesh procedure: retrospective study of 684 patients.

Authors:  Fréderic Caquant; Pierre Collinet; Philippe Debodinance; Juan Berrocal; Olivier Garbin; Claude Rosenthal; Henri Clave; Richard Villet; Bernard Jacquetin; Michel Cosson
Journal:  J Obstet Gynaecol Res       Date:  2008-08       Impact factor: 1.730

9.  The mechanism of urinary continence in women with severe uterovaginal prolapse: results of barrier studies.

Authors:  R C Bump; J A Fantl; W G Hurt
Journal:  Obstet Gynecol       Date:  1988-09       Impact factor: 7.661

10.  The risk of developing urinary stress-incontinence after vaginal repair in continent women. A clinical and urodynamic follow-up study.

Authors:  E Borstad; T Rud
Journal:  Acta Obstet Gynecol Scand       Date:  1989       Impact factor: 3.636

View more
  7 in total

1.  Urethral pressure reflectometry in women with pelvic organ prolapse: a study of reproducibility.

Authors:  Yasmine Khayyami; Gunnar Lose; Niels Klarskov
Journal:  Int Urogynecol J       Date:  2016-11-08       Impact factor: 2.894

2.  Incidence and Risk Factors of De novo Stress Urinary Incontinence after Pelvic Floor Reconstruction: A Nested Case-control Study.

Authors:  Shi-Yan Wang; Ting-Ting Cao; Run-Zhi Wang; Xin Yang; Xiu-Li Sun; Jian-Liu Wang
Journal:  Chin Med J (Engl)       Date:  2017-03-20       Impact factor: 2.628

3.  Short-term outcomes of the transvaginal minimal mesh procedure for pelvic organ prolapse.

Authors:  Naoko Takazawa; Akiko Fujisaki; Yasukuni Yoshimura; Akira Tsujimura; Shigeo Horie
Journal:  Investig Clin Urol       Date:  2018-02-02

4.  The urethral closure mechanism is deteriorated after anterior colporrhaphy.

Authors:  Yasmine Khayyami; Gunnar Lose; Niels Klarskov
Journal:  Int Urogynecol J       Date:  2017-11-04       Impact factor: 2.894

5.  Occurrence of pre- and postoperative stress urinary incontinence in 105 patients who underwent tension-free vaginal mesh surgery for pelvic organ prolapse: a retrospective study.

Authors:  Haruhiko Kanasaki; Aki Oride; Tomomi Mitsuo; Kohji Miyazaki
Journal:  ISRN Obstet Gynecol       Date:  2014-02-06

6.  Predictors of persistent stress urinary incontinence after transvaginal mesh repair.

Authors:  Shohei Kawaguchi; Kazutaka Narimoto; Satoko Urata; Masami Takeyama; Yoshifumi Kadono; Atsushi Mizokami
Journal:  BMC Womens Health       Date:  2018-10-25       Impact factor: 2.809

7.  Comparison of UpholdTM Vaginal Mesh Procedure with Hysterectomy or Uterine Preservation for the Treatment of Pelvic Organ Prolapse.

Authors:  Chin-Ru Ker; Kun-Ling Lin; Zi-Xi Loo; Yung-Shun Juan; Cheng-Yu Long
Journal:  Sci Rep       Date:  2018-06-21       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.